載入...
重组人血管内皮抑制素联合贝伐珠单抗体内抑瘤作用的效果及分析
BACKGROUND AND OBJECTIVE: The aim of this study is to investigate difference of antiangiogenesis ablility and interaction about bevacizumab and endostatin in vivo in lung cancer animal model. METHODS: First, we construct a Balb/c mice model with A549 lung adenocarcinoma cell. Then, we divide the mic...
Na minha lista:
| 發表在: | Zhongguo Fei Ai Za Zhi |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
中国肺癌杂志编辑部
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000393/ https://ncbi.nlm.nih.gov/pubmed/23425896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.01 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|